S100B's double life: Intracellular regulator and extracellular signal

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 6, 2009, Pages 1008-1022

  Donato, Rosario ^a   Sorci, Guglielmo ^a   Riuzzi, Francesca ^a   Arcuri, Cataldo ^a   Bianchi, Roberta ^a   Brozzi, Flora ^a   Tubaro, Claudia ^a   Giambanco, Ileana ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Development; Differentiation; Inflammation; Proliferation; RAGE; S100B; Signaling

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN S100B;

APOPTOSIS; ASTROCYTE; BRAIN DEVELOPMENT; CALCIUM HOMEOSTASIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CYTOSKELETON; ENZYME ACTIVITY; HEART MUSCLE CELL; HUMAN; MACROPHAGE; MICROGLIA; MONOCYTE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SATELLITE CELL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TISSUE REPAIR;

ANIMALS; CALCIUM; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSKELETON; HUMANS; NERVE GROWTH FACTORS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SIGNAL TRANSDUCTION;

MUS;

EID: 67349129131     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.11.009     Document Type: Review

References (247)

1. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 33 (2001) 637-668
2. Heizmann C.W., Fritz G., and Schaefer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 7 (2002) d1356-d1368
3. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
4. Marenholz I., Heizmann C.W., and Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322 (2004) 1111-1122
5. Santamaria-Kisiel L., Rintala-Dempsey A.C., and Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396 (2006) 201-214
6. Rambotti M.G., Giambanco I., Spreca A., and Donato R. S100B and S100A1 proteins in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry. Neuroscience 92 (1999) 1089-1101
7. Rickmann M., and Wolff J.R. S100 protein expression in subpopulations of neurons of rat brain. Neuroscience 67 (1995) 977-991
8. Hachem S., Aguirre A., Vives V., Marks A., Gallo V., and Legraverend C. Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia 51 (2005) 81-97
9. Vives V., Alonso G., Solal A.C., Joubert D., and Legraverend C. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J. Comp. Neurol. 457 (2003) 404-419
10. Deloulme J.C., Raponi E., Gentil B.J., Bertacchi N., Marks A., Labourdette G., and Baudier J. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol. Cell. Neurosci. (2004) 453-465
11. Sorci G., Bianchi R., Giambanco I., Rambotti M.G., and Donato R. Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B. Cell Calcium 25 (1999) 93-106
12. Arcuri C., Giambanco I., Bianchi R., and Donato R. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience 109 (2002) 371-388
13. Griffin S.W.T., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., and Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression. Brain Pathol. 8 (1998) 65-72
14. Mrak R.E., and Griffin W.S. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 22 (2001) 915-922
15. Van Eldik L.J., and Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 21 (2003) 97-108
16. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., and Parker T.G. S100β inhibits α1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J. Biol. Chem. 272 (1997) 31915-31921
17. Castets F., Griffin W.S.T., Marks A., and Van Eldik L.J. Transcriptional regulation of the human S100β gene. Mol. Brain Res. 46 (1997) 208-216
18. Muramatsu Y., Kurosaki R., Watanabe H., Michimata M., Matsubara M., Imai Y., and Araki T. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 42 (2003) 307-313
19. Adami C., Sorci G., Blasi E., Agneletti A.L., Bistoni F., and Donato R. S100B expression in and effects on microglia. Glia 33 (2001) 131-142
20. Ellis E.F., Willoughby K.A., Sparks S.A., and Chen T. S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons. J. Neurochem. 101 (2007) 1463-1470
21. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., and Griffin W.S. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17 (1996) 761-766
22. Peña L.A., Brecher C.W., and Marshak D.R. β-Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol. Brain Res. 34 (1995) 118-126
23. Manev H., Uz T., and Manev R. Glia as a putative target for antidepressant treatments. J. Affect. Disord. 75 (2003) 59-64
24. Djalali S., Höltje M., Grosse G., Rothe T., Stroh T., Grosse J., Deng D.R., Hellweg R., Grantyn R., Hörtnagl H., and Ahnert-Hilger G. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J. Neurochem. 92 (2005) 616-627
25. Iuvone T., Esposito G., De Filippis D., Bisogno T., Petrosino S., Scuderi C., Di Marzo V., and Steardo L. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. J. Mol. Med. 85 (2007) 1379-1392
26. Esposito G., Cirillo C., Sarnelli G., De Filippis D., D'Armiento F.P., Rocco A., Nardone G., Petruzzelli R., Grosso M., Izzo P., Iuvone T., and Cuomo R. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 133 (2007) 918-925
27. Saito T., Ikeda T., Nakamura K., Chung U.I., and Kawaguchi H. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep. 8 (2007) 504-509
28. Halonen S.K., Woods T., McInnerney K., and Weiss L.M. Microarray analysis of IFN-γresponse genes in astrocytes. J. Neuroimmunol. 175 (2006) 19-30
29. Raponi E., Agenes F., Delphin C., Assard N., Baudier J., Legraverend C., and Deloulme J.C. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 55 (2007) 165-177
30. Rustandi R.R., Baldisseri D.M., and Weber D.J. Structure of the negative regulatory domain of p53 bound to S100Bβ. Nat. Struct. Biol. 7 (2000) 570-574
31. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R., Marks A., and Dunn R.J. Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down's syndrome. Science 239 (1988) 1311-1313
32. Mrak R.E., and Griffin W.S. Trisomy 21 and the brain. J. Neuropathol. Exp. Neurol. 63 (2004) 679-685
33. Poelmans G., Engelen J.J., Van Lent-Albrechts J., Smeets H.J., Schoenmakers E., Franke B., Buitelaar J.K., Wuisman-Frerker M., Erens W., Steyaert J., and Schrander-Stumpel C. Identification of novel dyslexia candidate genes through the analysis of a chromosomal deletion. Am. J. Med. Genet. B. Neuropsychiatr. Genet. (2008) doi:10.1002/ajmg.b.30787
34. Shashoua V.E., Hesse G.W., and Moore B.W. Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J. Neurochem. 42 (1984) 1536-1541
35. Van Eldik L.J., and Zimmer D.B. Secretion of S100 from rat C6 glioma cells. Brain Res. 436 (1987) 367-370
36. Suzuki F., Kato K., and Nakajima T. Hormonal regulation of adipose S-100 protein release. J. Neurochem. 43 (1994) 1336-13341
37. 1A receptors. Brain Res. 528 (1990) 155-158
38. Pinto S.S., Gottfried C., Mendez A., Gonçalves D., Karl J., Gonçalves C.A., Wofchuk S., and Rodnight R. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett. 486 (2000) 203-207
39. 1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of Nerve Growth Factor and S100β protein from cultured astrocytes. Glia 27 (1999) 275-281
40. Edwards M.M., and Robinson S.R. TNF-α affects the expression of GFAP and S100B: implications for Alzheimer's disease. J. Neural. Transm. 113 (2006) 1709-1715
41. Gerlach R., Demel G., König H.G., Gross U., Prehn J.H., Raabe A., Seifert V., and Kögel D. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141 (2006) 1697-1701
42. 2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J. Biol. Chem. 276 (2001) 30819-30826
43. de Almeida L.M., Piñeiro C.C., Leite M.C., Brolese G., Tramontina F., Feoli A.M., Gottfried C., and Gonçalves C.A. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell. Mol. Neurobiol. 27 (2007) 661-668
44. Abib R.T., Quincozes-Santos A., Nardin P., Wofchuk S.T., Perry M.L., Gonçalves C.A., and Gottfried C. Epicatechin gallate increases glutamate uptake and S100B secretion in C6 cell lineage. Mol. Cell. Biochem. 310 (2008) 153-158
45. Funchal C., Tramontina F., Quincozes dos Santos A., Fraga de Souza D., Gonçalves C.A., Pessoa-Pureur R., and Wajner M. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells. J. Neurol. Sci. 260 (2007) 87-94
46. Quincozes-Santos A., Abib R.T., Leite M.C., Bobermin D., Bambini-Junior V., Gonçalves C.A., Riesgo R., and Gottfried C. Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol. Cell. Biochem. 314 (2008) 59-63
47. Sakatani S., Seto-Ohshima A., Shinohara Y., Yamamoto Y., Yamamoto H., Itohara S., and Hirase H. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J. Neurosci. 28 (2008) 10928-10936
48. Cochran A.J., Lu H.F., Li P.X., Saxton R., and Wen D.R. S-100 protein remains a practical marker for melanocytic and other tumours. Melanoma Res. 3 (1993) 325-330
49. Brochez L., and Naeyaert J.M. Serological markers for melanoma. Br. J. Dermatol. 143 (2000) 256-268
50. Harpio R., and Einarsson R. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin. Biochem. 37 (2004) 512-518
51. Rothermundt M., Peters M., Prehn J.H., and Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60 (2003) 614-632
52. Korfias S., Stranjalis G., Papadimitriou A., Psachoulia C., Daskalakis G., Antsaklis A., and Sakas D.E. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr. Med. Chem. 13 (2006) 3719-3731
53. Bloomfield S.M., McKinney J., Smith L., and Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6 (2007) 121-138
54. Kleindienst A., Hesse F., Bullock M.R., and Buchfelder M. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog. Brain Res. 161 (2007) 317-325
55. Dietrich M.O., Tort A.B., Schaf D.V., Farina M., Gonçalves C.A., Souza D.O., and Portela L.V. Increase in serum S100B protein level after a swimming race. Can. J. Appl. Physiol. 28 (2003) 710-716
56. Hasselblatt M., Mooren F.C., von Ahsen N., Keyvani K., Fromme A., Schwarze-Eicker K., Senner V., and Paulus W. Serum S100β increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62 (2004) 1634-1636
57. Mazzini G.S., Schaf D.V., Vinadé E.R., Horowitz E., Bruch R.S., Brunm L.M., Gonçalves C.A., Bacal F., Souza D.O., Portela L.V., and Bordignon S. Increased S100B serum levels in dilated cardiomyopathy patients. J. Card. Fail. 13 (2007) 850-854
58. Mazzini G.S., Schaf D.V., Oliveira A.R., Gonçalves C.A., Belló-Klein A., Bordignon S., Bruch R.S., Campos G.F., Vassallo D.V., Souza D.O., and Portela L.V. The ischemic rat heart releases S100B. Life Sci. 77 (2005) 882-889
59. Anderson R.E., Hansson L.O., Nilsson O., Dijlai-Merzoug R., and Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 48 (2001) 1255-1258
60. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108 (2001) 949-955
61. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., and Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83 (2005) 876-886
62. Perrone L., Peluso G., and Melone M.A. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. J. Cell. Physiol. 217 (2008) 60-71
63. Morbini P., Villa C., Campo I., Zorzetto M., Inghilleri S., and Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?. Mod. Pathol. 19 (2006) 1437-1445
64. Nardin P., Tramontina F., Leite M.C., Tramontina A.C., Quincozes-Santos A., de Almeida L.M., Battastini A.M., Gottfried C., and Gonçalves C.A. S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem. Int. 50 (2007) 774-782
65. Gonçalves, D., Karl, J., Leite, M., Rotta, L., Salbego, C., Rocha, E., Wofchuk, S., Gonçalves, C.A. High glutamate decreases S100B secretion stimulated by serum deprivation in astrocytes. Neuroreport 27;13 (2002) 1533-1535.
66. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., and Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
67. Donato R. RAGE: a single receptor for several ligands and different cellular responses. The case of certain S100 proteins. Curr. Mol. Med. 7 (2007) 711-724
68. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., Heizmann C.W., Kroneck P.M., and Fritz G. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26 (2007) 3868-3878
69. Ma W., Lee S.E., Guo J., Qu W., Hudson B.I., Schmidt A.M., and Barile G.R. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1355-1361
70. Xie J., Reverdatto S., Frolov A., Hoffmann R., Burz D.S., and Shekhtman A. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 283 (2008) 27255-27269
71. Schneider M., Hansen J.L., and Sheikh S.P. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?. J. Mol. Med. 86 (2008) 507-522
72. Heizmann C.W., Ackermann G.E., and Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 45 (2007) 93-138
73. Rescher U., and Gerke V. S100A10/p11: family, friends and functions. Pflugers Arch. 455 (2008) 575-582
74. Foell D., Wittkowski H., and Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3 (2007) 382-390
75. Markowitz J., MacKerell Jr. A.D., and Weber D.J. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins. Mini. Rev. Med. Chem. 7 (2007) 609-616
76. Tarabykina S., Griffiths T.R., Tulchinsky E., Mellon J.K., Bronstein I.B., and Kriajevska M. Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr. Cancer Drug Targets 7 (2007) 217-228
77. Most P., Remppis A., Pleger S.T., Katus H.A., and Koch W.J. S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R568-R577
78. Svenningsson P., and Greengard P. p11 (S100A10)-an inducible adaptor protein that modulates neuronal functions. Curr. Opin. Pharmacol. 7 (2007) 27-32
79. Zimmer D.B., Wright Sadosky P., and Weber D.J. Molecular mechanisms of S100-target protein interactions. Microsc. Res. Tech. 60 (2003) 552-559
80. Emberley E.D., Murphy L.C., and Watson P.H. S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell. Biol. 82 (2004) 508-515
81. Eckert R.L., Broome A.M., Ruse M., Robinson N., Ryan D., and Lee K. S100 proteins in the epidermis. J. Invest. Dermatol. 123 (2004) 23-33
82. Garrett S.C., Varney K.M., Weber D.J., and Bresnick A.R. S100A4, a mediator of metastasis. J. Biol. Chem. 281 (2006) 677-680
83. Moroz O.V., Dodson G.G., Wilson K.S., Lukanidin E., and Bronstein I.B. Multiple structural states of S100A12: a key to its functional diversity. Microsc. Res. Tech. 60 (2003) 581-592
84. Kwon M., MacLeod T.J., Zhang Y., and Waisman D.M. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front. Biosci. 10 (2005) 300-325
85. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., and Maciag T. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 116 (2003) 4871-4881
86. Donato R. Calcium independent, pH regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro. J. Biol. Chem. 263 (1988) 106-110
87. Sorci G., Agneletti A.L., and Donato R. Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines. Neuroscience 99 (2000) 773-783
88. Donato R. Quantitative analysis of the interaction between S-100 proteins and brain tubulin. Cell Calcium 8 (1987) 283-297
89. Baudier J., and Cole R.D. Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 263 (1988) 5876-5883
90. Yu W.H., and Fraser P.E. S100β interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J. Neurosci. 21 (2001) 2240-2246
91. Ferguson P.L., and Shaw G.S. Human S100B protein interacts with the Escherichia coli division protein FtsZ in a calcium-sensitive manner. J. Biol. Chem. 279 (2004) 18806-18813
92. Skripnikova E.V., and Gusev N.B. Interaction of smooth muscle caldesmon with S-100 protein. FEBS Lett. 257 (1989) 380-382
93. Hai C.M., and Gu Z. Caldesmon phosphorylation in actin cytoskeletal remodeling. Eur. J. Cell Biol. 85 (2006) 305-309
94. Gunning P., O'Neill G., and Hardeman E. Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol. Rev. 88 (2008) 1-35
95. Mbele G.O., Deloulme J.C., Gentil B.J., Delphin C., Ferro M., Garin J., Takahashi M., and Baudier J. The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes. J. Biol. Chem. 277 (2002) 49998-50007
96. Briggs M.W., and Sacks D.B. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 4 (2003) 571-574
97. Watanabe T., Wang S., Noritake J., Sato K., Fukata M., Takefuji M., Nakagawa M., Izumi N., Akiyama T., and Kaibuchi K. Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev. Cell 7 (2004) 871-883
98. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell. Dev. Biol. 21 (2005) 247-269
99. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008) 178-201
100. Millward T.A., Heizmann C.W., Schäfer B.W., and Hemmings B.A. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17 (1998) 5913-5922
101. Hergovich A., Cornils H., and Hemmings B.A. Mammalian NDR protein kinases: from regulation to a role in centrosome duplication. Biochim. Biophys. Acta 1784 (2008) 3-15
102. 2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase. J. Biol. Chem. 278 (2003) 6710-6718
103. 2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry 42 (2003) 14416-14426
104. Baudier J., Delphin C., Grunwald D., Khochbin S., and Lawrence J.J. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 11627-11631
105. 2+-dependent interaction of S100B(ββ) with a peptide derived from p53. Biochemistry 37 (1998) 1951-1960
106. Kuribayashi K., and El-Deiry W.S. Regulation of programmed cell death by the p53 pathway. Adv. Exp. Med. Biol. 615 (2008) 201-221
107. Riley T., Sontag E., Chen P., and Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell. Biol. 9 (2008) 402-412
108. Joerger A.C., and Fersht A.R. Structural Biology of the Tumor Suppressor p53. Annu. Rev. Biochem. 77 (2008) 557-582
109. Lin J., Yang Q., Yan Z., Markowitz J., Wilder P.T., Carrier F., and Weber D.J. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J. Biol. Chem. 279 (2004) 34071-34077
110. Wilder P.T., Lin J., Bair C.L., Charpentier T.H., Yang D., Liriano M., Varney K.M., Lee A., Oppenheim A.B., Adhya S., Carrier F., and Weber D.J. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim. Biophys. Acta 1763 (2006) 1284-1297
111. Scotto C., Delphin C., Deloulme J.C., and Baudier J. Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C. Mol. Cell. Biol. 19 (1999) 7168-7180
112. Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4735-4740
113. Arcuri C., Bianchi R., Brozzi F., and Donato R. S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to NGF via Akt activation. J. Biol. Chem. 280 (2005) 4402-4414
114. Chargé S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 8 (2004) 209-238
115. Zammit P.S., Partridge T.A., and Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54 (2006) 1177-1191
116. Brack A.S., and Rando T.A. Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 3 (2007) 226-237
117. Le Grand F., and Rudnicki M.A. Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol. 19 (2007) 628-633
118. Landry C.F., Ivy G.O., Dunn R.J., Marks A., and Brown I.R. Expression of the gene encoding the beta-subunit of S-100 protein in the developing rat brain analyzed by in situ hybridization. Brain Res. Mol. Brain Res. 6 (1989) 251-262
119. Reymond A., Marigo V., Yaylaoglu M.B., Leoni A., Ucla C., Scamuffa N., Caccioppoli C., Dermitzakis E.T., Lyle R., Banfi S., Eichele G., Antonarakis S.E., and Ballabio A. Human chromosome 21 gene expression atlas in the mouse. Nature 420 (2002) 582-586
120. Hachem S., Laurenson A.S., Hugnot J.P., and Legraverend C. Expression of S100B during embryonic development of the mouse cerebellum. BMC Dev. Biol. 15 (2007) 7-17
121. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., and Baldwin Jr. A.S. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289 (2000) 2363-2366
122. Mourkioti F., Kratsios P., Luedde T., Song Y.H., Delafontaine P., Adami R., Parente V., Bottinelli R., Pasparakis M., and Rosenthal N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116 (2006) 2945-2954
123. Bakkar N., Wang J., Ladner K.J., Wang H., Dahlman J.M., Carathers M., Acharyya S., Rudnicki M.A., Hollenbach A.D., and Guttridge D.C. IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180 (2008) 787-802
124. Xiong Z., O'Hanlon D., Becker L.E., Roder J., MacDonald J.F., and Marks A. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp. Cell Res. 257 (2000) 281-289
125. Hashimoto T., Gamou S., Shimizu N., Kitajima Y., and Nishikawa T. Regulation of translocation of the desmoyokin/AHNAK protein to the plasma membrane in keratinocytes by protein kinase C. Exp. Cell Res. 217 (1995) 258-266
126. Haase H., Podzuweit T., Lutsch G., Hohaus A., Kostka S., Lindschau C., Kott M., Kraft R., and Morano I. Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK. FASEB J. 13 (1999) 2161-2172
127. 2+ homeostasis regulation by S100B. J. Biol. Chem. 276 (2001) 23253-23261
128. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., and Parker T.G. Inhibition of norepinephrine-induced cardiac hypertrophy in S100β transgenic mice. J. Clin. Invest. 102 (1998) 1609-1616
129. Tsoporis J.N., Marks A., Haddad A., Dawood F., Liu P.P., and Parker T.G. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 111 (2005) 598-606
130. Tsoporis J.N., Marks A., Van Eldik L.J., O'Hanlon D., and Parker T.G. Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H193-H203
131. Shiojima I., and Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20 (2006) 3347-3365
132. Ahuja P., Sdek P., and MacLellan W.R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87 (2007) 521-544
133. Agulhon C., Petravicz J., McMullen A.B., Sweger E.J., Minton S.K., Taves S.R., Casper K.B., Fiacco T.A., and McCarthy K.D. What is the role of astrocyte calcium in neurophysiology?. Neuron 59 (2008) 932-946
134. 2+-binding protein S100B: role in D2 receptor function. Mol. Pharmacol. 74 (2008) 371-378
135. Khan Z.U., Koulen P., Rubinstein M., Grandy D.K., and Goldman-Rakic P.S. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1964-1969
136. Ohta K., Kuno S., Mizuta I., Fujinami A., Matsui H., and Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 73 (2003) 617-626
137. Li A., Guo H., Luo X., Sheng J., Yang S., Yin Y., Zhou J., and Zhou J. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 20 (2006) 1263-1265
138. Kligman D., and Marshak D.R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Scad. Sci. U. S. A. 82 (1985) 7136-7139
139. Winningham-Major F., Staecker J.L., Barger S.W., Coats S., and Van Eldik L.J. Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109 (1989) 3036-3071
140. Haglid K.G., Yang Q., Hamberger A., Bergman S., Widerberg A., and Danielsen N. S100β stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants. Brain Res. 753 (1997) 196-201
141. Van Eldik L.J., Christie-Pope B., Bolin L.M., Shooter E.M., and Whetsell Jr. W.O. Neurotrophic activity of S100β in cultured dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542 (1991) 280-285
142. Bhattacharyya A., Oppenheim R.W., Prevette D., Moore B.W., Brackenbury R., and Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vitro. J. Neurobiol. 23 (1992) 451-466
143. 1A agonist, S100b, and corticosteroid receptor agonists. Synapse 23 (1996) 1-9
144. Ueda S., Leonardi E.T.K., Bell J., and Azmitia E.C. Serotoninergic sprouting into transplanted C-6 gliomas is blocked by S100β antisense gene. Mol. Brain Res. 29 (1995) 365-368
145. Alexanian A.R., and Bamburg J.R. Neuronal survival activity of S100ββ is enhanced by calcineurin inhibitors and requires activation of NF-κB. FASEB J. 13 (1999) 1611-1620
146. Barger S.W., Van Eldik L.J., and Mattson M.P. S100β protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677 (1995) 167-170
147. Iwasaki Y., Shiojima T., and Kinoshita M. S100β prevents the death of motor neurons in newborn rats after sciatic nerve section. J. Neurol. Sci. 151 (1997) 7-12
148. 1A-receptor agonist, Bay × 3702. Brain Res. 858 (2000) 121-128
149. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., and Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J. Biol. Chem. 275 (2000) 40096-40105
150. Businaro R., Leone S., Sorci G., Donato R., Lauro G.M., and Fumagalli L. S100B protects LAN-5 neuroblastoma cells against Aβ amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high doses. J. Neurosci. Res. 83 (2006) 897-906
151. Kögel D., Peters M., König H.G., Hashemi S.M., Bui N.T., Arolt V., Rothermundt M., and Prehn J.H. S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 127 (2004) 913-920
152. Pichiule P., Chavez J.C., Schmidt A.M., and Vannucci S.J. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J. Biol. Chem. 282 (2007) 36330-36340
153. Kleindienst A., McGinn M.J., Harvey H.B., Colello R.J., Hamm R.J., and Bullock M.R. Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. J. Neurotrauma 22 (2005) 645-655
154. Kleindienst A., and Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J. Neurotrauma 23 (2006) 1185-1200
155. Willoughby K.A., Kleindienst A., Müller C., Chen T., Muir J.K., and Ellis E.F. S100B protein is released by in vitro trauma and reduces delayed neuronal injury. J. Neurochem. (2004) 1284-1291
156. 1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Res. 1030 (2004) 201-220
157. Tramontina F., Tramontina A.C., Souza D.F., Leite M.C., Gottfried C., Souza D.O., Wofchuk S.T., and Gonçalves C.A. Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes. Cell. Mol. Neurobiol. 26 (2006) 81-86
158. Reali C., Scintu F., Pillai R., Donato R., Michetti F., and Sogos V. S100B counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia. J. Neurosi. Res. 81 (2005) 677-686
159. Schmitt K.R., Kern C., Lange P.E., Berger F., Abdul-Khaliq H., and Hendrix S. S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth. Neurosci. Res. 59 (2007) 68-73
160. Huttunen H.J., Fages C., and Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274 (1999) 19919-19924
161. Wang L., Li S., and Jungalwala F.B. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth. J. Neurosci. Res. 86 (2008) 254-266
162. Sorci G., Riuzzi F., Arcuri C., Giambanco I., and Donato R. Amphoterin stimulates myogenesis and counteracts the anti-myogenic factors, bFGF and S100B, via RAGE binding. Mol. Cell. Biol. 24 (2004) 4880-4894
163. Rong L.L., Trojaborg W., Qu W., Kostov K., Yan S.D., Gooch C., Szabolcs M., Hays A.P., and Schmidt A.M. Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J. 18 (2004) 1812-1817
164. Spreca A., Rambotti M.G., Rende M., Saccardi C., Aisa M.C., Giambanco I., and Donato R. Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves. J. Histochem. Cytochem. 37 (1989) 441-446
165. Toth C., Martinez J., and Zochodne D.W. RAGE, diabetes, and the nervous system. Curr. Mol. Med. 7 (2007) 766-776
166. Leclerc E., Fritz G., Weibel M., Heizmann C.W., and Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282 (2007) 31317-31331
167. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., and Feldman E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148 (2007) 548-558
168. Wainwright M.S., Craft J.M., Griffin W.S., Marks A., Pineda J., Padgett K.R., and Van Eldik L.J. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann. Neurol. 56 (2004) 61-67
169. Craft J.M., Watterson D.M., Marks A., and Van Eldik L.J. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β-amyloid. Glia 51 (2005) 209-216
170. Mori T., Tan J., Arendash G.W., Koyama N., Nojima Y., and Town T. Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia. Stroke 39 (2008) 2114-2121
171. Esposito G., Imitola J., Lu J., De Filippis D., Scuderi C., Ganesh V.S., Folkerth R., Hecht J., Shin S., Iuvone T., Chesnut J., Steardo L., and Sheen V. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum. Mol. Genet. 17 (2008) 440-457
172. Verkman A.S., Binder D.K., Bloch O., Auguste K., and Papadopoulos M.C. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochim. Biophys. Acta 1758 (2006) 1085-1093
173. Richardson J.R., Caudle W.M., Wang M., Dean E.D., Pennell K.D., and Miller G.W. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J. 20 (2006) 1695-1697
174. Sheng J.G., Mrak R.E., Rovnaghi C.R., Kozlowska E., Van Eldik L.J., and Griffin W.S.T. Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17 (1996) 359-363
175. Reeves R.H., Yao J., Crowley M.R., Buck S., Zhang X., Yarowsky P., Gearhart J.D., and Hilt D.C. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5359-5363
176. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J., and Azmitia E.C. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776 (1997) 51-60
177. Shapiro L.A., and Whitaker-Azmitia P.M. Expression levels of cytoskeletal proteins indicate pathological aging of S100B transgenic mice: an immunohistochemical study of MAP-2, drebrin and GAP-43. Brain Res. 1019 (2004) 39-46
178. Shapiro L.A., Marks A., and Whitaker-Azmitia P.M. Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome. Brain Res. 1010 (2004) 17-21
179. Gerlai R., and Roder J. Spatial and nonspatial learning in mice: effects of S100β overexpression and age. Neurobiol. Learn. Mem. 66 (1996) 143-154
180. Tsai M.C., Shen L.F., Kuo H.S., Cheng H., and Chak K.F. Involvement of aFGF in spinal cord injury repair processes revealed by a proteomic approach. Mol. Cell. Proteomics 7 (2008) 1668-1687
181. Petrova V., Hu J., and Van Eldik L.J. Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res. 853 (2000) 74-80
182. Hu J., Ferreira A., and Van Eldik L.J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69 (1997) 2294-2301
183. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005) 349-354
184. Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia 46 (2008) 1636-1641
185. Bialowas-McGoey L.A., Lesicka A., and Whitaker-Azmitia P.M. Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging. Glia 56 (2008) 1780-1790
186. Esposito G., Scuderi C., Lu J., Savani C., De Filippis D., Iuvone T., Steardo Jr. L., Sheen V., and Steardo L. S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. J. Cell. Mol. Med. 12 (2008) 914-927
187. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
188. Goedert M., and Spillantini M.G. A century of Alzheimer's disease. Science 314 (2006) 777-781
189. Li Y., Wang J., Sheng J.G., Liu L., Barger S.W., Jones R.A., Van Eldik L.J., Mrak R.E., and Griffin W.S. S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71 (1998) 1421-1428
190. Sheng J.G., Mra K.R.E., Bales K.R., Cordell B., Paul S.M., Jones R.A., Woodward S., Zhou X.Q., McGinness J.M., and Griffin W.S. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J. Neurochem. 74 (2000) 295-301
191. Azmitia E.C., Dolan K., and Whitaker-Azmitia P.M. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res. 516 (1990) 354-356
192. Liu J.P., and Lauder J.M. S-100β and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33 (1992) 248-256
193. Ueda S., Gu X.F., Whitaker-Azmitia P.M., Naruse I., and Azmitia E.C. Neuro-glial neurotrophic interaction in the S-100β retarded mutant mouse (Polydactyly Nagoya) I. Immunocytochemical and neurochemical studies. Brain Res. 633 (1994) 275-283
194. Ueda S., Kokotos Leonardi E.T., Bell III J., and Azmitia E.C. Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100β antisense gene. Brain Res. Mol. Brain Res. 29 (1995) 365-368
195. Nishiyama H., Takemura M., Takeda T., and Itohara S. Normal development of serotonergic neurons in mice lacking S100B. Neurosci. Lett. 32 (2002) 49-52
196. Nishiyama H., Knopfel T., Endo S., and Itohara S. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4037-4042
197. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta 1450 (1999) 191-231
198. Kubista H., Donato R., and Hermann A. S100 calcium binding protein affects neuronal electrical discharge activity by modulation of potassium currents. Neuroscience 90 (1999) 493-508
199. Rothermundt M., Ponath G., and Arolt V. S100B in schizophrenic psychosis. Int. Rev. Neurobiol. 59 (2004) 445-470
200. Liu J., Shi Y., Tang J., Guo T., Li X., Yang Y., Chen Q., Zhao X., He G., Feng G., Gu N., Zhu S., Liu H., and He L. SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem. Biophys. Res. Commun. 328 (2005) 335-341
201. van Beveren N.J., van der Spelt J.J., de Haan L., and Fekkes D. Schizophrenia-associated neural growth factors in peripheral blood. A review. Eur. Neuropsychopharmacol. 16 (2006) 469-480
202. Steiner J., Bielau H., Bernstein H.G., Bogerts B., and Wunderlich M.T. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J. Neurol. Neurosurg. Psychiatry 77 (2006) 1284-1287
203. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., and Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26 (2006) 4752-4762
204. Hanson D.R., and Gottesman I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med. Genet. 6 (2005) 7
205. Clynes R., Moser B., Yan S.F., Ramasamy R., Herold K., and Schmidt A.M. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr. Mol. Med. 7 (2007) 743-751
206. Payne H.l.L. The role of transmembrane AMPA receptor regulatory proteins (TARPs) in neurotransmission and receptor trafficking (Review). Mol. Membr. Biol. 25 (2008) 353-362
207. Selinfreund R.H., Barger S.W., Pledger W.J., and Van Eldik L.J. Neurotrophic protein S100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3554-3558
208. Hu J., Castets F., Guevara J.L., and Van Eldik L.J. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271 (1996) 2543-2547
209. Lam A.G., Koppal T., Akama K.T., Guo L., Craft J.M., Samy B., Schavocky J.P., Watterson D.M., and Van Eldik L.J. Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol. Aging 22 (2001) 765-772
210. Hu J., and Van Eldik L.J. S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta 1313 (1996) 239-245
211. Hu J., and Van Eldik L.J. Glial-derived proteins activate cultured astrocytes and enhance β-amyloid-induced glial activation. Brain Res. 842 (1999) 46-54
212. Ponath G., Schettler C., Kaestner F., Voigt B., Wentker D., Arolt V., and Rothermundt M. Autocrine S100B effects on astrocytes are mediated via RAGE. J. Neuroimmunol. (2007) 214-222
213. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., and Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270 (1995) 25752-25761
214. Alarcon R., Fuenzalida C., Santibanez M., and von Bernhardi R. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J. Biol. Chem. 280 (2005) 30406-30415
215. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., and Yan S.D. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171 (2001) 29-45
216. Sasaki N., Takeuchi M., Chowei H., Kikuchi S., Hayashi Y., Nakano N., Ikeda H., Yamagishi S., Kitamoto T., Saito T., and Makita Z. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci. Lett. 326 (2003) 117-122
217. Ma L., and Nicholson L.F. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Res. 1018 (2004) 10-17
218. Lue L.F., Yan S.D., Stern D.M., and Walker D.G. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 249-266
219. Adami C., Bianchi R., Pula G., and Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 1742 (2004) 169-177
220. Bianchi R., Adami C., Giambanco I., and Donato R. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81 (2007) 108-118
221. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
222. Bianchi R., Giambanco I., and Donato R. S100B/RAGE-dependent activation of microglia via NF-κB and AP-1. Co-regulation of COX-2 expression by S100B and IL-1β and TNF-α. Neurobiol. Aging (2008) doi:10.1016/j.neurobiolaging.2008.05.017
223. Kim S.H., Smith C.J., and Van Eldik L.J. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol. Aging. 25 (2004) 431-439
224. Shanmugam N., Kim Y.S., Lanting L., and Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 278 (2003) 33444-34834
225. Shanmugam N., Ransohoff R.M., and Natarajan R. Interferon-γ-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. J. Biol. Chem. 281 (2006) 31212-31221
226. Valencia J.V., Mone M., Koehne C., Rediske J., and Hughes T.E. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 47 (2004) 844-852
227. Ding Y., Kantarci A., Hasturk H., Trackman P.C., Malabanan A., and Van Dyke E. Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J. Leukoc. Biol. 81 (2007) 520-527
228. Esposito G., De Filippis D., Cirillo C., Sarnelli G., Cuomo R., and Iuvone T. Astroglial-derived S100β protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sci. 78 (2006) 2707-2715
229. Omori K., Ohira T., Uchida Y., Ayilavarapu S., Batista Jr. E.L., Yagi M., Iwata T., Liu H., Hasturk H., Kantarci A., and Van Dyke T.E. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J. Leukoc. Biol. 84 (2008) 292-301
230. Ghanem G., Loir B., Morandini R., Sales F., Lienard D., Eggermont A., Lejeune F., and EORTC Melanoma Group. On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int. J. Cancer. 94 (2001) 586-590
231. Bubici C., Papa S., Dean K., and Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25 (2006) 6731-6748
232. Saini A., Al-Shanti N., and Stewart C.E. Waste management-cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 17 (2006) 475-486
233. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97 (2006) 439-447
234. Yan S.S., Wu Z.Y., Zhang H.P., Furtado G., Chen X., Yan S.F., Schmidt A.M., Brown C., Stern A., LaFaille J., Chess L., Stern D.M., and Jiang H. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat. Med. 9 (2003) 287-293
235. Ohtaki N., Kamitani W., Watanabe Y., Hayashi Y., Yanai H., Ikuta K., and Tomonaga K. Downregulation of an astrocyte-derived inflammatory protein, S100B, reduces vascular inflammatory responses in brains persistently infected with Borna disease virus. J. Virol. 81 (2007) 940-948
236. Feng L., Matsumoto C., Schwartz A., Schmidt A.M., Stern D.M., and Pile-Spellman J. Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care 28 (2005) 379-384
237. Gao X., Zhang H., Schmidt A.M., and Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type II diabetic mice. Am. J. Physiol. Heart. Circ. Physiol. 295 (2008) H491-H498
238. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., and Nawroth P.P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198 (2003) 1507-1515
239. Shaw S.S., Schmidt A.M., Banes A.K., Wang X., Stern D.M., and Marrero M.B. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 52 (2003) 2381-2388
240. Reddy M.A., Li S.L., Sahar S., Kim Y.S., Xu Z.G., Lanting L., and Natarajan R. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 281 (2006) 13685-13693
241. van Deurs B., Roepstorff K., Hommelgaard A.M., and Sandvig K. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13 (2003) 92-100
242. Parton R.G., and Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell. Biol. 8 (2007) 185-194
243. Kim Y.S., Kim N.H., Lee S.W., Lee Y.M., Jang D.S., and Kim J.S. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Eur. J. Pharmacol. 569 (2007) 171-179
244. Sorci G., Agneletti A.L., Riuzzi F., Marchetti C., and Donato R. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23 (2003) 4870-4881
245. Riuzzi F., Sorci G., and Donato R. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J. Cell. Physiol. 207 (2006) 461-470
246. Fanò G., Mariggiò M.A., Angelella P., Nicoletti I., Antonica A., Fulle S., and Calissano P. The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience 53 (1993) 919-925
247. Sorci G., Riuzzi F., Agneletti A.L., Marchetti C., and Donato R. S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J. Cell. Physiol. 199 (2004) 274-283